Published in Transfusion on July 01, 1995
Intraoperative red blood cell salvage and autologous transfusion during open radical retropubic prostatectomy: a cost-benefit analysis. Ann R Coll Surg Engl (2011) 1.50
Cost benefits of intraoperative cell salvage in radical cystectomy. Indian J Urol (2010) 1.10
Prostate cancer: 6. Surgical treatment of localized disease. CMAJ (1998) 1.00
Acute normovolemic hemodilution. Eur Spine J (2004) 0.86
Blood conservation strategies in orthopedic surgeries: A review. J Clin Orthop Trauma (2013) 0.76
Is acute normovolemic hemodilution cost-effective? Transfusion (1996) 0.75
Tissue oxidative metabolism after extreme hemodilution with PEG-conjugated hemoglobin. J Appl Physiol (1985) (2010) 0.75
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol (1992) 4.79
Transfusion medicine. First of two parts--blood transfusion. N Engl J Med (1999) 4.21
Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res (2001) 3.45
Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics. JAMA (1998) 3.19
The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery. Transfusion (1994) 3.03
Prudent strategies for elective red blood cell transfusion. Ann Intern Med (1992) 2.98
Transfusion medicine. Second of two parts--blood conservation. N Engl J Med (1999) 2.95
Mathematical modeling of platelet survival with implications for optimal transfusion practice in the chronically platelet transfusion-dependent patient. Transfusion (1998) 2.86
Patient preferences for location of care: implications for regionalization. Med Care (1999) 2.57
Lack of efficacy for conventional gamma irradiation of platelet concentrates to abrogate bacterial growth. Am J Clin Pathol (1998) 2.56
A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med (1995) 2.49
Potential reduction in mortality rates using an intensivist model to manage intensive care units. Eff Clin Pract (2001) 2.35
Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol (1994) 2.25
Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular atrial fibrillation. Ann Intern Med (1999) 2.15
Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone. Ann Intern Med (1994) 2.10
Operative mortality with elective surgery in older adults. Eff Clin Pract (2001) 2.06
Aprotinin prolongs whole blood activated partial thromboplastin time but not whole blood prothrombin time in patients undergoing cardiac surgery. Anesth Analg (1995) 2.06
A new era in blood conservation. Ann Thorac Surg (1991) 2.05
Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol (1995) 2.05
Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. Am J Hum Genet (2001) 2.03
Longitudinal screening for prostate cancer with prostate-specific antigen. JAMA (1996) 1.97
The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med (1994) 1.96
Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy. Transfusion (1998) 1.93
A method for dinitrochlorobenzene contact sensitization. A clinicopathological study. N Engl J Med (1972) 1.88
A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol (1992) 1.84
Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection. J Urol (1994) 1.81
Visual identification of bacterially contaminated red cells. Transfusion (1992) 1.81
The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg (1995) 1.80
Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men. J Urol (1998) 1.80
Case mix, quality and high-cost kidney transplant patients. Am J Transplant (2009) 1.79
Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients. Ann Thorac Surg (2000) 1.78
The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors. Ann Intern Med (1999) 1.73
Safety of the blood supply in the United States: opportunities and controversies. Ann Intern Med (1997) 1.71
Clinical use of prostate specific antigen in patients with prostate cancer. J Urol (1989) 1.71
Prevalence of HLA sensitization in female apheresis donors. Transfusion (1999) 1.70
Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening. J Urol (1996) 1.70
A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol (2000) 1.69
Safety and cost-effectiveness of solvent-detergent-treated plasma. In search of a zero-risk blood supply. JAMA (1994) 1.67
The effect of hospital volume on mortality and resource use after radical prostatectomy. J Urol (2000) 1.60
Genomewide scan for prostate cancer-aggressiveness loci. Am J Hum Genet (2000) 1.57
Acute normovolemic hemodilution can replace preoperative autologous blood donation as a standard of care for autologous blood procurement in radical prostatectomy. Anesth Analg (1997) 1.56
Cardiologists performing peripheral angioplasties: impact on utilization. Eff Clin Pract (2001) 1.56
Impaired prostate tumorigenesis in Egr1-deficient mice. Nat Med (2001) 1.55
A genome screen of multiplex sibships with prostate cancer. Am J Hum Genet (2000) 1.51
Tissue factor expression and angiogenesis in human prostate carcinoma. Hum Pathol (2000) 1.50
A prospective study comparing the complication rates between laparoscopic and open ventral hernia repairs. Surg Endosc (2003) 1.49
Transfusion Medicine Illustrated. RBC rosetting and erythrophagocytosis in adult paroxysmal cold hemoglobinuria. Transfusion (2001) 1.49
Response of kaolin ACT to heparin: evaluation with an automated assay and higher heparin doses. Ann Thorac Surg (1996) 1.48
Cost-effectiveness of head CT in patients with lung cancer without clinical evidence of metastases. Chest (1995) 1.45
The effects of donor and recipient practices on transplant center finances. Am J Transplant (2008) 1.44
Leukocyte reduction in blood component therapy. Ann Intern Med (1992) 1.44
Acute preoperative hemodilution in patients undergoing radical prostatectomy: a case study analysis of efficacy. Anesth Analg (1994) 1.42
A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology (1999) 1.41
Prestorage removal of Yersinia enterocolitica from red cells with white cell-reduction filters. Transfusion (1992) 1.41
Cost-effectiveness analysis in surgery. Surgery (1998) 1.40
The implications of cost-effectiveness for autologous blood procurement. Arch Pathol Lab Med (1994) 1.40
Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity? Bone Marrow Transplant (2000) 1.39
Selective in vivo removal of rheumatoid factor by an extracorporeal treatment device in rheumatoid arthritis patients. Transfusion (1991) 1.39
Radical surgery for advanced prostate cancer and for radiation failures. J Urol (1992) 1.38
Antegrade approach to radical retropubic prostatectomy in patients with difficult apical dissection. J Urol (1991) 1.38
Expectant management and the natural history of localized prostate cancer. J Urol (1994) 1.38
Cost-effectiveness of surgery for small abdominal aortic aneurysms on the basis of data from the United Kingdom small aneurysm trial. J Vasc Surg (2000) 1.38
A standardized method for calculating blood loss. Transfusion (1997) 1.37
Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma. Hum Pathol (2001) 1.37
Pain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomized trial of 6 versus 12 cores. J Urol (2000) 1.36
The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion (1993) 1.34
Primary treatment choices for men with clinically localized prostate carcinoma detected by screening. Cancer (2000) 1.34
Visual estimate of the percentage of carcinoma is an independent predictor of prostate carcinoma recurrence after radical prostatectomy. Cancer (2000) 1.34
Lymphocyte reactivity in cancer patients: correlation with tumor histology and clinical stage. Cancer (1973) 1.33
Requirement of a thymus dependent immune response for BCG-mediated antitumor activity. J Urol (1987) 1.33
Effect of coronary artery diameter in patients undergoing coronary bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation (1996) 1.33
Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study Group. Arch Surg (1998) 1.28
Prosthetic valve type for patients undergoing aortic valve replacement: a decision analysis. Ann Thorac Surg (2000) 1.27
Adverse events in platelet apheresis donors: A multivariate analysis in a hospital-based program. Vox Sang (1999) 1.27
The early detection of prostate carcinoma with prostate specific antigen: the Washington University experience. Cancer (1997) 1.25
T-cell subsets required for intravesical BCG immunotherapy for bladder cancer. J Urol (1993) 1.24
Endocrine therapy for bladder outlet obstruction from carcinoma of the prostate. J Urol (1985) 1.24
Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. Urology (1993) 1.23
Optimal platelet dosing. Transfusion (1999) 1.23
Bacillus Calmette-Guérin and superficial bladder cancer. Clinical experience and mechanism of action. Surg Annu (1990) 1.22
Serum glycoproteins in cancer patients: first report of correlations with in vitro and in vivo parameters of cellular immunity. Cancer (1980) 1.22
Interexaminer variability of digital rectal examination in detecting prostate cancer. Urology (1995) 1.22
Correlation of preoperative lymphocyte reactivity with the clinical course of cancer patients. Surg Gynecol Obstet (1973) 1.21
Anemia, transfusion, and mortality. N Engl J Med (2001) 1.21
Thrombopoietin therapy increases platelet yields in healthy platelet donors. Blood (2001) 1.20
Retrospective analysis of transfusion outcomes in pregnant patients at a tertiary obstetric center. Int J Obstet Anesth (2009) 1.19
Iron overload and toxicity: the hidden risk of multiple blood transfusions. Vox Sang (2009) 1.19
Artificial neural networks in the diagnosis and prognosis of prostate cancer: a pilot study. J Urol (1994) 1.19
National trends in utilization and outcomes of antireflux surgery. Surg Endosc (2003) 1.18
Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes. Clin Exp Immunol (1975) 1.17
Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions. Transfusion (2001) 1.16
The nature of prostate cancer detected through prostate specific antigen based screening. J Urol (1994) 1.16
Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis. Urology (1999) 1.16
Abnormalities of quantitative dinitrochlorobenzene sensitization in cancer patients: correlation with tumor stage and histology. Cancer (1973) 1.16
Quantitative dinitrochlorobenzene contact sensitization in a normal population. Clin Exp Immunol (1972) 1.15